
Proto Labs (PRLB): The CEO Bought Shares. Should You?
Price: $44.96 (+1.72%) as of Aug-06-2025 🧪
Ticker: PRLB
Mood: ⚙️ Cautiously Curious
Tagline: From Prototypes to Portfolios — Is This One a Fit?
🧲 What Just Happened?
The CEO of Proto Labs, Suresh Krishna, just bought some shares.
Not a life-changing amount — but enough to raise a curious eyebrow. 👀
📅 Filing Date: 2025-08-06
📆 Trade Date: 2025-08-04
💰 Purchase: 1,725 shares @ $43.51
🧮 Total Investment: $75,055
📈 Ownership Bump: +11%
A modest buy, sure, but CEOs don’t usually throw money at their own company unless they believe in it. So let’s ask: Should we?
🚀 New Sheriff in Town: CEO Suresh Krishna Rides In!
🗓️ Appointed: May 21, 2025
🏢 Company: Proto Labs, Inc.
🧑💼 New Role: President & CEO (and Board Member!)
✨ Experience: Over 30 years of leading profitable growth and shareholder value creation in the manufacturing world.
🛠️ Last Stop: President & CEO of Northern Tool + Equipment, a mega-manufacturer and retailer of tools serving millions of customers annually.
🎯 Mission Objective:
👉 Capture a bigger bite of the $100 billion digital manufacturing pie.
👉 Leverage Proto Labs’ mix of digital factories, network power, and prototyping leadership to boost growth and dominate a fragmented market.
💥 New CEO. New energy. New opportunity.
Let’s see if the market—and investors—are ready to tool up! 🧰📈
🏦 Institutions Believe, Too
Wall Street royalty is on board. Check out these names:
🧑💼 Holder | 📦 Shares | 📆 Date | 🧮 % of PRLB | 💵 Value |
---|---|---|---|---|
BlackRock | 3.86M | Mar 2025 | 16.2% | $173.7M |
Vanguard | 2.83M | Mar 2025 | 11.8% | $127.0M |
DGI | 2.67M | Mar 2025 | 11.2% | $120.1M |
DFA | 1.32M | Mar 2025 | 5.6% | $59.6M |
State Street | 1.12M | Mar 2025 | 4.7% | $50.4M |
👑 Total institutional ownership: 93.75%
That’s a lot of belief in one small-cap company.
🔍 For Proto Labs ($PRLB)'s Institutional Ownership breakdown, see here.
💰 Financial Snapshot (Q2 2025)
✅ Revenue: $135.1M (+7.5% YoY)
✅ Digital Factory Revenue: $105.8M (+4.8%)
✅ Protolabs Network Revenue: $29.3M (+18.6%)
✅ Non-GAAP Net Income: $10.0M or $0.41 per share
✅ Adjusted EBITDA: $19.7M (14.6% margin)
✅ Cash & Investments: $123.2M
✅ Customer Contacts: 21,775
✅ Revenue per Customer: $6,203 (+10.9%)
🗣️ CEO Suresh Krishna:
“We generated record quarterly revenue and are executing in a dynamic and uncertain environment.”
Translation: The team is building something — and it’s starting to show.
🔭 Q3 2025 Outlook
📉 Revenue Estimate: $130M – $138M
📉 EPS Estimate: $0.17 – $0.25
📈 Non-GAAP EPS Estimate: $0.35 – $0.43
👉 Want the full picture? Dive into Proto Labs ($PRLB)'s financials here.
📊 Valuation Metrics
Some ratios scream “expensive,” others whisper “reasonable.” You decide.
📏 Metric | Value |
---|---|
Trailing P/E | 74.93 😬 |
Price/Sales | 2.17 ✅ |
Price/Book | 1.61 ✅ |
EV/EBITDA | Reasonable-ish 🤷 |
⚖️ Verdict: Not cheap, but not a nosebleed either.
📈 Chart Watch: Base Camp Formed?
Technically, PRLB has been bottoming for 3 years — like a patient rock climber prepping to summit.
🐂 A possible bull run may have started back in Nov 2024.
🧗 Will it reach new heights… or just plateau?
🧪 The Case For Proto Labs
✅ Strong and steady revenue growth
✅ Profitability in a tricky sector
✅ Broad institutional support
✅ Technically constructive chart
✅ CEO + Institutions = Alignment
🚧 But Beware...
❗ Modest insider buy — symbolic, not shocking, nearly cosmetic
❗ Fierce competition: 3D printing, CNC, traditional custom shops
❗ High P/E — margin of safety? Questionable.
❗ The market itself feels heavy — any correction could hit PRLB
❗ Still has to prove long-term earnings growth
💡💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.
🤔 So… Should You Prototype a Position?
Maybe — but prototype your position sizing too.
🔁 Start small.
📉 Watch pullbacks.
🎯 Aim near the CEO’s entry price.
💬 And don't expect overnight miracles.
⚠️ Disclaimer:
PRLB may or may not become your portfolio's MVP. But hey — at least you'll learn a thing or two about custom parts and precision manufacturing.
We’re not financial advisors. We’re FUNancial advisors.
We laugh, we analyze, we meme — we do not provide investment advice. It’s just a second opinion — and yes, we’re billing your sense of humor. 🎪💸
Invest at your own risk, always DYOR, hold the FOMO, and don’t invest what you can’t afford to lose.
🧭 Want More Like This?
- 🕵️ Insider Purchases Center
- 📣 Follow the Pundits Hub
- 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
- 😆 Stock Market Humor & Serious-ish Plays
- 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
- 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
- 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)
😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny
Other articles:
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
Got a thought? A tip? A tale? We’re all ears — drop it below.: